SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

A sharp rally is drawing attention after Morgan Stanley reiterated a bullish view, with traders also citing anticipation of Starship Flight 15 and momentum-driven buying. Bulls see a breakout and possible short squeeze, while skeptics point to stretched valuation and upcoming share unlocks.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavaxs sharp rise is being tied by traders to reports of a suspected plague outbreak linked to a Russian research lab, reviving pandemic-vaccine speculation and fueling talk of a possible short squeeze given the heavily shorted stock. The community is divided on whether the outbreak explains the move, with some instead citing Nuvaxovid partner approvals and Novavaxs royalty-based commercial model.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is drawing attention amid continued share-price weakness and concerns about how it will finance its capital-intensive AI infrastructure projects, with traders debating potential dilution and the lack of clear financing details. Bullish investors point to its contracted GPU/data-center projects and expected growth, while skeptics question management credibility and want clearer proof of execution and revenue conversion.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas stronger-than-expected Q3 vehicle deliveries have eased near-term demand concerns and fueled a sharp rebound, with traders watching whether momentum can clear technical resistance. Bulls point to the delivery beat, while skeptics question the valuation and cite margin concerns and weaker-than-expected energy-storage deployments.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOIs rally is being tied to traders belief that its large at-the-market share-sale program is complete, easing dilution pressure, alongside interest in AI data-center optics demand. Bulls see room for momentum to return, while skeptics remain concerned about dilution, volatility, and whether the rebound can hold.

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Vaxcyte Inc

Vaxcytes VAX-31 met the primary endpoints in its pivotal Phase 3 adult pneumococcal-vaccine trial, prompting a sharp share-price surge and optimism about its potential against Pfizer and Mercks vaccines. Traders are also debating whether to take profits or short the rally, with concerns about dilution from the companys announced stock and convertible-note offerings tempering bullish reactions.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riots shift from Bitcoin mining toward AI/HPC data centers is the main focus, with traders citing the Rockdale lease and speculating about a larger Corsicana tenant deal. Many are frustrated that the shares have lagged Bitcoin despite the expansion story, while bulls anticipate a re-rating and bears point to dilution concerns and weak momentum.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors 24-month HOPE-3 open-label extension data showed slower upper-limb decline among Duchenne muscular dystrophy patients who switched to deramiocel, bolstering the case for the therapy ahead of FDA review. Traders are split: some view the data as supportive of approval, while others focus on unresolved trial-statistics and regulatory concerns and an analysts continued expectation of a complete response letter; the stocks drop despite the positive data has also fueled debate about selling pressure.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Jobys steep slide toward 52-week lows is driving discussion, with traders citing cash burn and potential dilution, insider selling, and uncertainty over the timing of FAA certification. Some investors view the weakness as an accumulation opportunity and point to eIPP flights and autonomy milestones, while others remain concerned about the long path to commercialization.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Russia-related plague headlines are fueling interest in Emergents biodefense business, alongside speculation about a short squeeze and potential government contract awards. Traders are also debating a possible buyout, but anticipated awards and a squeeze remain unconfirmed.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
